又一家药企启动“A拆H”

新浪财经
Nov 04

来源:药智网近日,复星医药发布公告称,拟筹划分拆控股子公司复星安特金(系集团疫苗业务平台企业)于香港联交所上市;建议分拆上市有利于复星安特金进一步扩宽融资渠道、提升市场竞争力。值得一提的是,这只是药企分拆潮的冰山一角。01药企分拆潮这已经不是“复星系”第一次分拆。早在2019年,复星医药就成功分拆复宏汉霖到港股上市。复宏汉霖是采取“生物类似药+创新药”双轮驱动战略的药企。而此次复星医药分拆的复星...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10